---
schema_version: "secwatch.filing_event.v1"
accession: "0001999371-25-021283"
form_type: "8-K"
ticker: "TNXP"
cik: "0001430306"
company_name: "Tonix Pharmaceuticals Holding Corp."
filed_at: "2025-12-29T23:59:59+00:00"
generated_at: "2026-05-16T12:05:48.728428+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Tonix Pharmaceuticals prices $20M registered direct offering with Point72; shares and pre-funded warrants

## Summary
- Sold 615,025 shares at $16.26 and pre-funded warrants for 615,025 shares at $16.259 to Point72; gross proceeds ~$20M.
- Closing expected Dec 30, 2025; TD Cowen sole placement agent.
- Net proceeds to fund commercialization, pipeline development, and working capital.
- 30-day lock-up on additional equity issuance; 180-day ban on variable rate transactions.
- Directors and officers also subject to 30-day lock-up.

## SEC filing metadata
- accession: 0001999371-25-021283
- form_type: 8-K
- ticker: TNXP
- cik: 0001430306
- company_name: Tonix Pharmaceuticals Holding Corp.
- filed_at: 2025-12-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1430306/000199937125021283/0001999371-25-021283-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1430306/000199937125021283/tonix-8k_122925.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001999371-25-021283
- JSON: https://secwatch.observer/filing/0001999371-25-021283.json
- Plain text: https://secwatch.observer/filing/0001999371-25-021283.txt

## Key facts
- Material Agreements
  Tonix Pharmaceuticals Holding Corp. entered into Placement Agency Agreement with TD Securities (USA) LLC valued at 6.0% cash placement fee on gross proceeds; expense reimbursement up to $100,000 (effective 2025-12-29).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: TD Securities (USA) LLC
  - Value: 6.0% cash placement fee on gross proceeds; expense reimbursement up to $100,000
  - Effective: 2025-12-29
  source text: On December 29, 2025, the Company entered into a placement agency agreement (the "Placement Agency Agreement") with TD Securities (USA) LLC (the "Placement Agent"), pursuant to which the Placement Agent was engaged as the placement agent for the Offering.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1430306/000199937125021283/0001999371-25-021283-index.htm
- Material Agreements
  Tonix Pharmaceuticals Holding Corp. entered into Securities Purchase Agreement with a single institutional investor valued at $20.0 million gross proceeds; offering price per Share $16.26, per Pre-Funded Warrant $16.259 (effective 2025-12-29).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: a single institutional investor
  - Value: $20.0 million gross proceeds; offering price per Share $16.26, per Pre-Funded Warrant $16.259
  - Effective: 2025-12-29
  source text: On December 29, 2025, Tonix Pharmaceuticals Holding Corp. (the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with a single institutional investor (the "Purchaser").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1430306/000199937125021283/0001999371-25-021283-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.